However, a broader distribution was observed in TRBV gene usage among memory CD4+ cells from patients with WAS (Figure 7, lower panel), with increased usage of the TRBV30 and reduced usage of the TRBV7-9 genes as compared to controls. The gene discussed is CD4; the disease is Wiskott-Aldrich syndrome.